Pharmaceutical royalties:a new securitisation frontier (co-published editorial)
There are a number of specific issues that need to be considered whencontemplating the securitisation of royalties from pharmaceutical-related patents
Download
-
-
News & Analysis
-
-
- Categories
- News & Analysis
- Long Reads
- Opinion
-
-
- Reports
-
Data & Tools
-
-
- Tools
- GTDT
-
-
Rankings
-
-
- IAM Patent 1000
- Introduction
- All Firms
- All Individuals
-
- IAM Strategy 300
- Introduction
- All individuals
-
- Global Leaders
- IAM Global Leaders
- Strategy 300 Global Leaders
-
- IAM Analytics
- Patent 1000 Analytics
-
-
-
Insight
-
-
- Insight
- Guides
- Regional Reviews
- Market Insight
-
- Hub
- SEP/FRAND
-
-
-
Events
-
-
- Events
- IAM & IPBC events
- Diary
-
-
- IAM Market
-
- Login | Register